Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
Clinical trial NCT05041127 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05041127
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-27
- Primary completion
- 2026-09-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.